VXRT Vaxart Inc

USD 0.75 0.05 6.908364
Icon

Vaxart Inc (VXRT) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 0.749

+0.05 (+6.91)%

USD 0.12B

1.24M

USD 2.00(+167.02%)

USD 5.00 (+567.56%)

Icon

VXRT

Vaxart Inc (USD)
COMMON STOCK | NSD
USD 0.75
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 0.12B

USD 5.00 (+567.56%)

USD 0.75

Vaxart Inc (VXRT) Stock Forecast

USD 2.00
(+167.02%)

Based on the Vaxart Inc stock forecast from 1 analysts, the average analyst target price for Vaxart Inc is USD 2.00 over the next 12 months. Vaxart Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Vaxart Inc is Bearish, which is based on 1 positive signals and 6 negative signals. At the last closing, Vaxart Inc’s stock price was USD 0.749. Vaxart Inc’s stock price has changed by +13.76% over the past week, -39.60% over the past month and -14.30% over the last year.

No recent analyst target price found for Vaxart Inc
No recent average analyst rating found for Vaxart Inc

Company Overview Vaxart Inc

Vaxart, Inc., a clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, a bivalent oral tablet vaccine in Phase 2 clinical trial for t...Read More

https://vaxart.com

170 Harbor Way, South San Francisco, CA, United States, 94080

109

December

USD

USA

Adjusted Closing Price for Vaxart Inc (VXRT)

Loading...

Unadjusted Closing Price for Vaxart Inc (VXRT)

Loading...

Share Trading Volume for Vaxart Inc Shares

Loading...

Compare Performance of Vaxart Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for VXRT

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Vaxart Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc -1.98 (-0.49%) USD102.73B 28.66 20.00

ETFs Containing VXRT

Symbol Name VXRT's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Vaxart Inc (VXRT) Stock

Based on ratings from 1 analysts Vaxart Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 2 buy, sell and hold ratings.

Unfortunately we do not have enough data on VXRT's stock to indicate if its a good dividend stock.

Based on targets from 1 analysts, the average taret price for VXRT is USD 2.00 over the next 12 months. The maximum analyst target price is USD 2 while the minimum anlayst target price is USD 2.

Unfortunately we do not have enough data on VXRT's stock to indicate if its overvalued.

The last closing price of VXRT's stock was USD 0.75.

The most recent market capitalization for VXRT is USD 0.12B.

Based on targets from 1 analysts, the average taret price for VXRT is projected at USD 2.00 over the next 12 months. This means that VXRT's stock price may go up by +167.02% over the next 12 months.

We can't find any ETFs which contains Vaxart Inc's stock.

As per our most recent records Vaxart Inc has 109 Employees.

Vaxart Inc's registered address is 170 Harbor Way, South San Francisco, CA, United States, 94080. You can get more information about it from Vaxart Inc's website at https://vaxart.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...